Botox vs. Neuronox: The Comparison Guide
Reviewed for medical accuracy against our Medical Review Board · Last updated 15 August 2026
Part of Botox vs Other Neurotoxin Brands
Widely used across Asia, absent from US clinics. The comparison, and the reason for the gap.
Botox and Neuronox are both botulinum toxin type A products, but they come from different manufacturers and are approved in different parts of the world. Botox is made by AbbVie and approved by the FDA, while Neuronox is made by the Korean company Medytox and used widely across Asia and other international markets.
In this comprehensive guide, we will compare Botox and Neuronox in terms of how they work, what they treat, how long they last, costs, regulatory status, and which one might be available where you live. Whether you are a patient researching options abroad or simply curious about the brand, this guide will help you understand the difference with confidence.
1. Botox and Neuronox explained
1.1 Definitions and Origins
Botox (OnabotulinumtoxinA): A neuromodulator approved by the FDA in 2002 for cosmetic use. Developed by Allergan and now manufactured by AbbVie, Botox works by temporarily blocking nerve signals to specific facial muscles.
Neuronox: A botulinum toxin type A product manufactured by the South Korean company Medytox, marketed domestically as Meditoxin and internationally as Neuronox. It has been used across Asia for well over a decade.
1.2 Mechanism of Action
- Botox: Blocks acetylcholine, preventing muscle contraction. This softens lines caused by repetitive movement, such as frowning or squinting.
- Neuronox: Uses the same botulinum toxin type A mechanism, blocking acetylcholine release at the treated muscle in a broadly similar way to Botox.
1.3 FDA Approval and Global Use
- Botox: FDA approved and widely used for both cosmetic and medical indications in the United States.
- Neuronox: Not FDA approved and not available in the United States. It is approved by Korean regulators and used across many countries in Asia, the Middle East, and Latin America.
2. Botox vs Neuronox: the differences that matter
2.A Purpose and Function
- Botox: Prevents and smooths dynamic wrinkles caused by muscle movement.
- Neuronox: Serves the same cosmetic purpose in the markets where it is approved and sold.
2.B Regional Availability
| Region | Botox | Neuronox |
|---|---|---|
| United States | ✅ | ❌ |
| South Korea | ✅ | ✅ |
| Southeast Asia | ✅ | ✅ |
| Middle East | ✅ | ✅ |
| Latin America | ✅ | ✅ (select markets) |
| European Union | ✅ | Limited |
2.C Onset and Duration
- Botox: Results appear in 3–5 days, peak at 2 weeks, and last 3–4 months.
- Neuronox: Manufacturer data suggests a similar onset and duration, typically 3–4 months.
2.D Formulation
- Botox: Supplied as a vacuum-dried powder that requires reconstitution with saline before injection.
- Neuronox: Also supplied as a powder requiring reconstitution, following a similar preparation process to Botox.
3. How well each one actually works
3.A Anti-Aging Focus
- Botox: Best for expression lines, including the forehead, crow's feet, and between the brows.
- Neuronox: Used for the same cosmetic areas in markets where it is available, with published studies showing comparable results to onabotulinumtoxinA.
3.B Longevity of Results
| Product | Typical Duration |
|---|---|
| Botox | 3–4 months |
| Neuronox | 3–4 months |
3.C Is One More Effective?
- Published studies generally show non-inferiority against reference botulinum toxin A products, though outside research remains limited.
4. Pricing compared
4.A Average Cost Per Session
- Botox: $12–$20 per unit in the United States. Common areas cost $250–$600 per session.
- Neuronox: Typically priced lower than Botox locally, reflecting regional manufacturing costs.
4.B Total Treatment Cost by Area
| Area | Botox (avg., US) | Neuronox (avg., int'l markets) |
|---|---|---|
| Forehead Lines | $250–$500 | Lower cost regionally |
| Full Face | $600–$1,000 | Lower cost regionally |
| Glabella Only | $200–$400 | Lower cost regionally |
4.C Maintenance Costs
- Botox typically requires repeat treatment every 3–4 months.
- Neuronox follows a similar retreatment schedule in the regions where it is used.
4.D Insurance Coverage
- Botox may be partially covered for medical uses, such as migraines, in the United States.
- Neuronox coverage depends entirely on local insurance systems outside the United States.
5. How safe is each one
5.A Common Side Effects
- Botox: Redness, swelling, bruising, temporary headache.
- Neuronox: Similar injection site effects reported in published studies.
5.B Rare Risks
- Botox: Eyelid drooping (ptosis), uneven results, resistance over time.
- Neuronox: Similar rare risks, though outside data is less extensive than for Botox.
5.C Downtime
- Botox: Minimal, most patients return to activities the same day.
- Neuronox: Minimal, consistent with other botulinum toxin type A products.
6. Ideal Candidates: Who Should Choose Which?
Botox Is Best For:
- Patients located in the United States or countries where Botox is the approved option.
- Individuals who want the most extensively studied, long-term safety record.
- Patients seeking a provider familiar with FDA labeling and dosing.
Neuronox Is Best For:
- Patients located in South Korea or other markets where it is approved.
- Individuals seeking a lower cost option within an approved regional market.
- Patients working with a licensed local provider familiar with the product.
Factors to Consider
- Whether the product is legally approved in your country
- Your provider's specific experience with the chosen brand
- Access to authentic, traceable product rather than unauthorized imports
7. Real-World Experience & Expert Opinions
7.1 What Providers Say
- Botox remains the most studied and widely trusted botulinum toxin brand globally.
- Neuronox has a long track record across Asia, where it holds significant market share.
- Providers stress that unit dosing is not interchangeable between the two products.
7.2 Patient Perspectives
- "I chose Neuronox because it was the widely available, approved option where I live."
- "My provider explained that Botox and Neuronox are not dosed the same way."
- "I always confirm my provider sources authentic product with proper documentation."
7.3 Key Takeaways
- Both are legitimate botulinum toxin type A products where properly approved and sourced.
- Regulatory approval and provider experience matter more than the brand name alone.
8. Switching Between Botox and Neuronox
8.1 Is It Safe to Switch Brands?
Yes, when performed by an experienced injector. Since units are not directly interchangeable, your provider will recalculate dosing rather than substituting a Neuronox amount directly for a Botox amount.
8.2 How Providers Handle a Switch
- Your injector reviews your previous results and dosing history
- Dosing is recalculated for the new product's specific unit potency
- Results are monitored at your next follow-up to fine-tune future treatments
8.3 Planning Tips
- Tell your provider which product you have used previously
- Confirm the product is approved and authentic locally
- Ask about differences in onset, spread, and duration before switching
9. Medical vs. Cosmetic Uses
| Use Case | Botox | Neuronox |
|---|---|---|
| Dynamic Wrinkle Reduction | ✅ | ✅ |
| FDA Approved (US) | ✅ | ❌ |
| Chronic Migraine (US) | ✅ | ❌ |
| Approved in Asia | ✅ | ✅ |
| Global Long-Term Data | Extensive | Regional |
Botox has the broadest global approval and the deepest safety record. Neuronox serves as an established, lower cost option in the specific markets where it is approved.
10. Decision Guide: Botox or Neuronox?
10.1 What to Consider
- Is the product legally approved and available where you live?
- How much long-term safety data matters to your decision?
- Is your provider experienced with the specific brand you are considering?
10.2 Consultation Tips
- Ask your provider which product they use and why
- Request documentation confirming authentic, traceable product
- Discuss expected units, cost, and duration before treatment
10.3 Choosing the Right Provider
- Choose a licensed provider in a regulated clinic
- Confirm the product is approved for use in that country
- Avoid any provider unwilling to disclose their product source
Final Thoughts: Botox vs. Neuronox
Botox and Neuronox are both botulinum toxin type A products, but they are approved in different parts of the world. Botox holds FDA approval and the most extensive global safety record. Neuronox has an established history across Asia and other international markets.
If you are in the United States, Botox is your approved option. If you are in a market where Neuronox is authorized, it can be a legitimate, lower cost alternative when sourced through a licensed provider.
Always confirm a product's regulatory status in your country and choose a licensed provider using authentic, traceable product.
